These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28283079)

  • 21. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
    Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour-bearing dogs (excluding mast cell tumours): a phase I dose-finding study.
    Chon E; McCartan L; Kubicek LN; Vail DM
    Vet Comp Oncol; 2012 Sep; 10(3):184-93. PubMed ID: 22235941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [COX-2 inhibitor and colon cancer].
    Tsujii M
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1799-805. PubMed ID: 11729471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
    Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer.
    Levy GN
    FASEB J; 1997 Mar; 11(4):234-47. PubMed ID: 9068612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonsteroidal anti-inflammatory drugs and corticosteroids for the management of canine osteoarthritis.
    Johnston SA; Budsberg SC
    Vet Clin North Am Small Anim Pract; 1997 Jul; 27(4):841-62. PubMed ID: 9243784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential role of selective COX-2 inhibitors in cancer management.
    Dang CT; Shapiro CL; Hudis CA
    Oncology (Williston Park); 2002 May; 16(5 Suppl 4):30-6. PubMed ID: 12102578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mediators of PGE2 synthesis and signalling downstream of COX-2 represent potential targets for the prevention/treatment of colorectal cancer.
    Chell S; Kaidi A; Williams AC; Paraskeva C
    Biochim Biophys Acta; 2006 Aug; 1766(1):104-19. PubMed ID: 16859832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of in vitro cytotoxicity of nonsteroidal anti-inflammatory drugs against canine tumor cells.
    Knapp DW; Chan TC; Kuczek T; Reagan WJ; Park B
    Am J Vet Res; 1995 Jun; 56(6):801-5. PubMed ID: 7653891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular measurement of prostaglandin E2: effect of anti-inflammatory drugs on cyclooxygenase activity and prostanoid expression.
    Horton JK; Williams AS; Smith-Phillips Z; Martin RC; O'Beirne G
    Anal Biochem; 1999 Jun; 271(1):18-28. PubMed ID: 10361000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacology, safety, efficacy and clinical uses of the COX-2 inhibitor robenacoxib.
    Lees P; Toutain PL; Elliott J; Giraudel JM; Pelligand L; King JN
    J Vet Pharmacol Ther; 2022 Jul; 45(4):325-351. PubMed ID: 35460083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
    In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis.
    Tanaka K; Suemasu S; Ishihara T; Tasaka Y; Arai Y; Mizushima T
    Eur J Pharmacol; 2009 Jan; 603(1-3):120-32. PubMed ID: 19101538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NSAIDs and breast cancer: a possible prevention and treatment strategy.
    Agrawal A; Fentiman IS
    Int J Clin Pract; 2008 Mar; 62(3):444-9. PubMed ID: 18194278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of direct cytotoxic effects of NSAIDs in the induction of gastric lesions.
    Tomisato W; Tsutsumi S; Hoshino T; Hwang HJ; Mio M; Tsuchiya T; Mizushima T
    Biochem Pharmacol; 2004 Feb; 67(3):575-85. PubMed ID: 15037209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The renal effects of NSAIDs in dogs.
    Lomas AL; Grauer GF
    J Am Anim Hosp Assoc; 2015; 51(3):197-203. PubMed ID: 25955147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional regulation of cyclooxygenase-2 gene expression: novel effects of nonsteroidal anti-inflammatory drugs.
    Yuan CJ; Mandal AK; Zhang Z; Mukherjee AB
    Cancer Res; 2000 Feb; 60(4):1084-91. PubMed ID: 10706128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells.
    Palayoor ST; Tofilon PJ; Coleman CN
    Clin Cancer Res; 2003 Aug; 9(8):3150-7. PubMed ID: 12912967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Robenacoxib in the dog: target species safety in relation to extent and duration of inhibition of COX-1 and COX-2.
    King JN; Arnaud JP; Goldenthal EI; Gruet P; Jung M; Seewald W; Lees P
    J Vet Pharmacol Ther; 2011 Jun; 34(3):298-311. PubMed ID: 21492194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest.
    Lees P; Landoni MF; Giraudel J; Toutain PL
    J Vet Pharmacol Ther; 2004 Dec; 27(6):479-90. PubMed ID: 15601442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.